HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Government Will Conduct Abortion Pill Review Amid Studies Showing Possible Dangers A recent report shows that more than 1 in 10 women experience adverse side effects from chemical abortions.

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the abortion pill, mifepristone, amid queries from Congress. Sen. Josh Hawley (R-MO) ...